Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination In the REDEFINE 1 phase 3a trial, semaglutide at a dose of 2.4 mg with cagrilintide at a dose of 2.4 mg led to significant body weight reduction in adults without diabetes and Dose Chart [Cagrilintide] GLP 1 Forum Cagrilintide 10mg Vial Proliven Labs Targeting the weight within: obesity pharmacotherapy in cardiovascular disease Medicine Today Peptides for Weight Loss Revolution Health & Wellness